Literature DB >> 21817060

Altered lipid metabolism in Hfe-knockout mice promotes severe NAFLD and early fibrosis.

Terrence C H Tan1, Darrell H G Crawford, Lesley A Jaskowski, Therese M Murphy, Mandy L Heritage, V Nathan Subramaniam, Andrew D Clouston, Gregory J Anderson, Linda M Fletcher.   

Abstract

The HFE protein plays a crucial role in the control of cellular iron homeostasis. Steatosis is commonly observed in HFE-related iron-overload disorders, and current evidence suggests a causal link between iron and steatosis. Here, we investigated the potential contribution of HFE mutations to hepatic lipid metabolism and its role in the pathogenesis of nonalcoholic fatty liver disease. Wild-type (WT) and Hfe knockout mice (Hfe(-/-)) were fed either standard chow, a monounsaturated low fat, or a high-fat, high-carbohydrate diet (HFD) and assessed for liver injury, body iron status, and markers of lipid metabolism. Despite hepatic iron concentrations and body weights similar to WT controls, Hfe(-/-) mice fed the HFD developed severe hypoxia-related steatohepatitis, Tnf-α activation, and mitochondrial respiratory complex and antioxidant dysfunction with early fibrogenesis. These features were associated with an upregulation in the expression of genes involved in intracellular lipid synthesis and trafficking, while transcripts for mitochondrial fatty acid β-oxidation and adiponectin signaling-related genes were significantly attenuated. In contrast, HFD-fed WT mice developed bland steatosis only, with no inflammation or fibrosis and no upregulation of lipogenesis-related genes. A HFD led to reduced hepatic iron in Hfe(-/-) mice compared with chow-fed mice, despite higher serum iron, decreased hepcidin expression, and increased duodenal ferroportin mRNA. In conclusion, our results demonstrate that Hfe(-/-) mice show defective hepatic-intestinal iron and lipid signaling, which predispose them toward diet-induced hepatic lipotoxicity, accompanied by an accelerated progression of injury to fibrosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21817060     DOI: 10.1152/ajpgi.00150.2011

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  10 in total

1.  Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease.

Authors:  Kris V Kowdley; Patricia Belt; Laura A Wilson; Matthew M Yeh; Brent A Neuschwander-Tetri; Naga Chalasani; Arun J Sanyal; James E Nelson
Journal:  Hepatology       Date:  2011-12-06       Impact factor: 17.425

2.  Lower serum hepcidin and greater parenchymal iron in nonalcoholic fatty liver disease patients with C282Y HFE mutations.

Authors:  James E Nelson; Elizabeth M Brunt; Kris V Kowdley
Journal:  Hepatology       Date:  2012-09-20       Impact factor: 17.425

Review 3.  Diagnostic and therapeutic implications of the association between ferritin level and severity of nonalcoholic fatty liver disease.

Authors:  Luca Valenti; Paola Dongiovanni; Silvia Fargion
Journal:  World J Gastroenterol       Date:  2012-08-07       Impact factor: 5.742

4.  Probiotics modify tight-junction proteins in an animal model of nonalcoholic fatty liver disease.

Authors:  David Briskey; Mandy Heritage; Lesley-Anne Jaskowski; Jonathan Peake; Glenda Gobe; V Nathan Subramaniam; Darrell Crawford; Catherine Campbell; Luis Vitetta
Journal:  Therap Adv Gastroenterol       Date:  2016-05-01       Impact factor: 4.409

5.  Heterozygous Hfe gene deletion leads to impaired glucose homeostasis, but not liver injury in mice fed a high-calorie diet.

Authors:  Laurence Britton; Lesley Jaskowski; Kim Bridle; Nishreen Santrampurwala; Janske Reiling; Nick Musgrave; V Nathan Subramaniam; Darrell Crawford
Journal:  Physiol Rep       Date:  2016-06

6.  Mouse models of hereditary hemochromatosis do not develop early liver fibrosis in response to a high fat diet.

Authors:  John Wagner; Carine Fillebeen; Tina Haliotis; Edouard Charlebois; Angeliki Katsarou; Jeannie Mui; Hojatollah Vali; Kostas Pantopoulos
Journal:  PLoS One       Date:  2019-08-23       Impact factor: 3.240

7.  A Low Iron Diet Protects from Steatohepatitis in a Mouse Model.

Authors:  Lipika Salaye; Ielizaveta Bychkova; Sandy Sink; Alexander J Kovalic; Manish S Bharadwaj; Felipe Lorenzo; Shalini Jain; Alexandria V Harrison; Ashley T Davis; Katherine Turnbull; Nuwan T Meegalla; Soh-Hyun Lee; Robert Cooksey; George L Donati; Kylie Kavanagh; Herbert L Bonkovsky; Donald A McClain
Journal:  Nutrients       Date:  2019-09-10       Impact factor: 5.717

Review 8.  Iron and non-alcoholic fatty liver disease.

Authors:  Laurence J Britton; V Nathan Subramaniam; Darrell Hg Crawford
Journal:  World J Gastroenterol       Date:  2016-09-28       Impact factor: 5.742

9.  Combination curcumin and vitamin E treatment attenuates diet-induced steatosis in Hfe-/- mice.

Authors:  Mandy Heritage; Lesley Jaskowski; Kim Bridle; Catherine Campbell; David Briskey; Laurence Britton; Linda Fletcher; Luis Vitetta; V Nathan Subramaniam; Darrell Crawford
Journal:  World J Gastrointest Pathophysiol       Date:  2017-05-15

10.  Matriptase-2 deficiency protects from obesity by modulating iron homeostasis.

Authors:  Alicia R Folgueras; Sandra Freitas-Rodríguez; Andrew J Ramsay; Cecilia Garabaya; Francisco Rodríguez; Gloria Velasco; Carlos López-Otín
Journal:  Nat Commun       Date:  2018-04-10       Impact factor: 14.919

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.